Our Story
- Home
- Our Story
The conventional concept of medicine is undergoing a drastic change, and medical treatment, which has been segmented by organ, is now undergoing a revolution. “Gut microbiota” and “fecal microbiota transplantation” play a major role in the future that can be achieved through harmony with microorganisms.
The nanobubbles that support our technology are expected to be used in many fields as an environmentally friendly and safe technology because they are multifunctional and made from nothing but air and water.
Welcome to Shinbiosis, where we are exploring what we can do now for the future of our planet.

Shinbiosis Corporation
Representative DirectorMikiko Tanaka
Biography and Qualifications
- Born Jul. 15, 1962Type O blood, Cancer zodiac sign
- Mar. 1985Graduated from Kobe Jogakuin University, Faculty of Letters
- Apr. 1985Joined Asahi Broadcasting Corporation, Radio Production Department
- Feb. 1988Retired from Asahi Broadcasting Corporation Radio Production Department
-
Oct. 1988Opened a preschool and tutoring school at home
Worked for a trading company (in preparation for starting a business) - Feb. 2008Established Abilities Co.
- Oct. 2017Established Intestinal Flora Transplantation Clinical Research, Inc.
- Nov.2017Became a Council Member of the newly established General Foundation for Clinical Research on Intestinal Flora Transplantation
- 401 Est Nouveau, 2-1-40, Katamachi, Miyakojima-ku, Osaka-shi, Osaka 534-0025, Japan
-
Present :Representative Director of Symbiosis, Inc., Intestinal Flora Transplantation Clinical Research, Inc.
Councilor, Intestinal Flora Transplantation Clinical Research Foundation, Inc.
Contact Us

Reception hours: 10:00-17:00
[excluding Saturdays, Sundays,and holidays]